RECURRENT OR METASTATIC CERVICAL CANCER
Clinical trials for RECURRENT OR METASTATIC CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OR METASTATIC CERVICAL CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OR METASTATIC CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cervical cancer: MK-2870 trial launches
Disease control OngoingThis Phase 3 trial compares a new drug, MK-2870, against standard treatments for people with recurrent or metastatic cervical cancer that has progressed after initial therapy. About 686 participants will receive either MK-2870 or a doctor-chosen standard treatment. The main goal …
Matched conditions: RECURRENT OR METASTATIC CERVICAL CANCER
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug duo takes on multiple cancers in Mid-Stage trial
Disease control OngoingThis phase 2 study is testing a combination of two drugs, SKB264 and pembrolizumab (Keytruda), in 240 people with certain advanced solid tumors, including cervical, urothelial, ovarian, prostate, and endometrial cancers. The goal is to see if the combination is safe and effective…
Matched conditions: RECURRENT OR METASTATIC CERVICAL CANCER
Phase: PHASE2 • Sponsor: Klus Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC